Oral Magnesium Treatment Reduces Anemia and Levels of Inflammatory Markers in Experimental Diabetes

REFERENCES

• Alexandraki K, Piperi C, Kalofoutis C, Singh J, Alaveras A, Kalofoutis A. Inflammatory process in type 2 diabetes: The role of cytokines. Ann N Y Acad Sci. 2006;1084:89–117.
   Google Scholar
• Arun GS and Ramesh KG. Improvement of insulin sensitivity by perindopril in spontaneously hypertensive and streptozotocin diabetic rats. Indian J Pharmacol. 2002;34:156–164.
   Google Scholar
• Barbagallo M, Dominguez LJ. Magnesium metabolism in type 2 diabetes mellitus, metabolic syndrome and insulin resistance. Archives of Biochemistry and Biophysics. 2007;458(1):40–47.
   Google Scholar
• Barbieri J, Fontela PC, Winkelmann ER, Zimmermann CEP, Sandri YP, Mallet EKV, et al. Anemia in patients with type 2 diabetes mellitus. Anemia. 2015;2015: Article ID 354737, 1–7, doi:10.1155/2015/354737.
   Google Scholar
• Billett HH. Hemoglobin and hematocrit. In: Walker HK, HallWD, HurstJW (Eds.)Clinical methods: The history, physical, and laboratory examinations (3rd edition), Butterworths, Boston. 718–719, 1990.
   Google Scholar
• Bishop LM, Fody PE, Schoe HL. Clinical chemistry principles, procedures, correlations. 5th ed, Philadelphia: Lippincott, Williams & Wilkins, 2005.
   Google Scholar
• Castro C, Gourley M. Diagnostic testing and interpretation of tests for autoimmunity. J Allergy and Clin Immunol. 2010;125(2):S238–S247.
   Google Scholar
• Chacko SA, Sul J, Song Y, Li X, LeBlanc J, You Y, et al Magnesium supplementation, metabolic and inflammatory markers, and global genomic and proteomic profiling: a randomized, double-blind, controlled, crossover trial in overweight individuals. Am J Clin Nutr. 2011;93(2):463–473.
   Google Scholar
• Chacko SA, Song Y, Nathan L, Tinker L, de Boer IH, Tylavsky F, et al Relations of dietary magnesium intake to biomarkers of inflammation and endothelial dysfunction in an ethnically diverse cohort of postmenopausal women. Diabetes Care. 2010;33(2):304–310.
   Google Scholar
• Dandona P, Aljada A, Bandyopadhyay A. Inflammation: the link between insulin resistance, obesity and diabetes. Trends Immunol. 2004;25(1):4–7.
   Google Scholar
• Don BR, Kaysen G. Serum albumin: relationship to inflammation and nutrition. Semin Dial. 2004;17(6):432–437.
   Google Scholar
• Engstrom G, Stavenow L, Hedblad B, Lind P, Eriksson KF, Janzon L, et al Inflammation-sensitive plasma proteins, diabetes, and mortality and incidence of myocardial infarction and stroke: a population-based study. Diabetes. 2003;52(2):442–447.
   Google Scholar
• Fernandez-Real JM, Ricart W. Insulin resistance and chronic cardiovascular inflammatory syndrome. Endocr Rev. 2003;24:278–301.
   Google Scholar
• Ferrero-Miliani L, Nielsen OH, Anderson PS, Girardin SE. Chronic inflammation: importance of NOD2 and NALP3 in interleukin-1 beta generation. Clin Exp Immunol. 2007;147(2):227–235.
   Google Scholar
• Gusdon AM, Corbett JA, Matthews CE: Type 1 diabetes: Islet inflammation—the contribution of cytokines and beta cells. Drug Disc Today Disease Mech. 2006;3(3):367–372.
   Google Scholar
• Jain S, Gautam V, Naseem S. Acute-phase proteins: As diagnostic tool. J Pharm Bioallied Sci. 2011;3(1):118–127.
   Google Scholar
• King DE, Mainous AG, Geesey ME, Woolson RF. Dietary magnesium and C-reactive protein levels. J Am Coll Nutr. 2005;24:166–171.
   Google Scholar
• Kolanjiappan K, Manoharan S, Kayalvizhi M: Measurement of erythrocyte lipids, lipid peroxidation, antioxidants and osmotic fragility in cervical cancer patients. Clin Chim Acta. 2002;326:143–149.
   Google Scholar
• Kolb H, Mandrup-Poulsen T. The global diabetes epidemic as a consequence of lifestyle-induced low-grade inflammation. Diabetologia. 2010;53 (1):10–20.
   Google Scholar
• Lal J, Vasudev K, Kela AK, Jain SK: Effect of oral magnesium supplementation on the lipid profile and blood glucose of patients with type 2 diabetes mellitus. J Assoc Physicians India. 2003;51:37–42.
   Google Scholar
• Libby P. Inflammation in atherosclerosis. Nature.2002;420:868–874.
   Google Scholar
• Mazur A, Maier JA, Rock E, Gueux E, Nowacki W, Rayssiguier Y. Magnesium and the inflammatory response: Potential physiopathological implications. Archives of Biochemistry and Biophysics. 2007;458:148–156.
   Google Scholar
• Millar HR, Simpson JG, Stalker AL. An evaluation of the heat precipitation method for plasma fibrinogen estimation. J Clin Pathol. 1971;24(9):827–830.
   Google Scholar
• Navarro-González JF, Mora-Fernández C. The role of inflammatory cytokines in diabetic nephropathy. J Am Soc Nephrol. 2008;19:433–442.
   Google Scholar
• Ohshita K, Yamane K, Hanafusa M, Mori H, Mito K, Okubo M, et al Elevated white blood cell count in subjects with impaired glucose tolerance. Diabetes Care. 2004;27:491–496.
   Google Scholar
• Orchard TJ, Olson JC, Erbey JR, Williams K, Forrest KY, Smithline Kinder L, et al Insulin resistance-related factors, but not glycemia, predict coronary artery disease in type 1 diabetes: 10-year follow-up data from the Pittsburgh epidemiology of diabetes complications study. Diabetes Care. 2003;26:1374–1379.
   Google Scholar
• Oyedemi SO, Yakubu MT, Afolayan AJ. Antidiabetic activities of aqueous leaves extract of Leonotisleonrus in streptozotocin induced diabetic rats. J. Med Plant Res. 2011;5:119–125.
   Google Scholar
• Pertynska-Marczewska M, Kirikidis S, Wait R, Beech J, Feldmann M, Paleolog EM. Advanced glycation end products regulates angiogenic and pro-inflammatory cytokine production in human monocyte/macrophages. Cytokine. 2004;28:35–47.
   Google Scholar
• Pickup JC, Crook MA. Is type II diabetes mellitus a disease of the innate immune system?. Diabetologia. 1998;41:1241–1248.
   Google Scholar
• Reffelmann T, Ittermann T, Dorr M, Volzke H, Reinthaler M, Petersmann A, et al Low serum magnesium concentrations predicts cardiovascular and all cause mortality. Atherosclerosis. 2011;219(1):280–284.
   Google Scholar
• Ritchie RF, Palomaki GE, Neveux LM, Navolotskaia O, Ledue TB, Craig WY. Reference distributions for the negative acute-phase serum proteins, albumin, transferrin, and transthyretin: a practical, simple and clinically relevant approach in a large cohort. J Clin Lab Anal. 1999;13(6):273–279.
   Google Scholar
• Scherberich JE. Pro-inflammatory blood monocytes: main effector and target cells in systemic and renal disease; background and therapeutic implications. Int J Clin Pharmacol Ther. 2003;41:459–464.
   Google Scholar
• Schulze MB, Schulz M, Heidemann C, Schienkiewitz A, Hoffmann K, Boeing H. Fiber and magnesium intake and incidence of type 2 diabetes: a prospective study and meta analysis. Arch Intern Med. 2007;167:956–965.
   Google Scholar
• Schram MT, Chaturvedi N, Schalkwijk CG, Fuller JH, Stehouwer CDA. Markers of inflammation are cross-sectionally associated with microvascular complicationsand cardiovascular disease in type 1 diabetes—the EURODIAB Prospective Complications Study. Diabetologia 2005;48(2):370–378.
   Google Scholar
• Shurtz-Swirski R, Sela S, Herskovits AT, Shasha SM, Shapiro G, Nasser L, et al Involvement of peripheral polymorphonuclear leukocytes in oxidative stress and inflammation in type 2 diabetic patients. Diabetes Care. 2004;24:104–110.
   Google Scholar
• Singh VP, Bali A, Singh N, Jaggi AS. Advanced glycation end products and diabetic complications. Korean J Physiol Pharmacol. 2014;18(1):1–14.
   Google Scholar
• Szkudelski T. The mechanism of alloxan and streptozotocin action in B cells of the rat pancreas. Physiol Res. 2001;50(6):537–546.
   Google Scholar
• Tong PC, Lee KF, So WY, Ng MH, Chan WB, Lo MK, et al White blood cell count is associated with macro and microvascular complications in Chinese patients with type 2 diabetes. Diabetes Care. 2004;27:216–222.
   Google Scholar
• Trinder P. Determination of blood glucose using an oxidase-peroxidase system with a non-carcinogenic chromogen. J Clin Pathol. 1969;22(2):158–161.
   Google Scholar
• Wang C, Li S, Zhong XW, Li HQ, Fu XQ, Ran XW. Variance of mean platelet volume in subjects with normal glucose tolerance, impaired glucose regulation and type 2 diabetes mellitus and its relationship with diabetic peripheral artery disease. Zhonghua Yi Xue Za Chi 31.2012;92(4):232–235.
   Google Scholar
• Wang J, Persuitte G, Olendzki BC, Wedick NM, Zhang Z, Merriam PA, et al Dietary magnesium intake improves insulin resistance among non-diabetic individuals with metabolic syndrome participating in a dietary trial. Nutrients. 2013;5:3910–3919.
   Google Scholar
• Wang J, Wan R, Mo Y, Zhang Q, Sherwood LC, Chien S. Creating a long-term diabetic rabbit model. Exp Diabetes Res. 2010;2010:289614.
   Google Scholar
• Weiss G, Goodnough LT. Anemia of chronic disease. N Engl J Med. 2005;352:1011–1023.
   Google Scholar
• Westergren A. Diagnostic tests: the erythrocyte sedimentation rate range and limitations of the technique. Triangle. 1957;3 (1):20–25.
   Google Scholar
• World Health Organization.WHO Expert Committee on Specifications for Pharmaceutical Preparations—WHO Technical Report Series, No. 885—Thirty-fifth report, 1999.
   Google Scholar
• Yavuz Y, Mollaoglu H: Therapeutic effect of magnesium sulphate on carbon monoxide toxicity-mediated brain lipid peroxidation. Eur Rev Med Pharmacol Sci. 2013;17 Suppl 1:28–33.
   Google Scholar
• Zoppini G, Faccini G, Muggeo M, Zenari L, Falezza G, Targher G. Elevated plasma levels of soluble receptors of TNF-a and their association with smoking and microvascular complications in young adults with type 1 diabetes. J Clin Endocrinol Metabol. 2001;86:3805–3808.
   Google Scholar